XML 31 R20.htm IDEA: XBRL DOCUMENT v3.24.3
Net Loss Per Share
 8 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Net Loss Per Share

12. Net Loss per Share

 

Basic and diluted net loss per share attributable to stockholders were calculated as follows (in thousands, except share and per share data): 

 

   Three Months Ended
September 30,
2024		   Period from
February 6,
2024
(Inception)
to
September 30,
2024		 
   Loss Allocation   Weighted Average Shares Outstanding   Loss Per Share – Basic and Diluted   Loss Allocation   Weighted Average Shares Outstanding   Loss Per Share – Basic and Diluted 
Common Stock  $(21,936)   15,013,655   $(1.46)  $(47,192)   7,765,381   $(6.08)
Company Series A Preferred Stock(1)   (697)   477   $(1,460.62)   (1,121)   184   $(6,077.13)
Company Series B Preferred Stock(2)   (5,990)   49,191   $(121.77)   (9,630)   19,015   $(506.44)
Net loss  $(28,623)            $(57,943)          

 

(1)The weighted-average number of shares of as-converted Company Series A Preferred Stock used in the loss allocation was 477,196 and 184,462 for the three months ended September 30, 2024 and for the period from February 6, 2024 (inception) to September 30, 2024, respectively.

 

(2)The weighted-average number of shares of as-converted Company Series B Preferred Stock used in the loss allocation was 4,099,227 and 1,584,575 for the three months ended September 30, 2024 and for the period from February 6, 2024 (inception) to September 30, 2024, respectively.

 

For the computation of basic net loss per share attributable to stockholders, the amount of weighted-average shares outstanding excludes all shares of unvested restricted common stock as such shares are not considered outstanding for accounting purposes until vested. The amount of weighted-average shares outstanding includes the pre-funded warrants as the exercise price is negligible and these warrants are fully vested and exercisable.

 

The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to stockholders for the periods presented because including them would have had an anti-dilutive effect were as follows: 

 

   Three Months Ended
September 30,
2024		   Period from
February 6,
2024
(Inception)
to
September 30,
2024		 
Outstanding employee warrants to purchase common stock   3,054,358    3,054,358 
Outstanding unvested restricted stock awards   2,207,553    2,207,553 
Outstanding and issued common stock options   1,287,760    1,287,760 
Total   6,549,671    6,549,671